Navigation Links
Million dollar boost to Alzheimer's and stroke research at Robarts
Date:9/6/2009

The Canadian Institutes of Health Research (CIHR) has announced a grant totaling more than a million dollars for John F. MacDonald's research on Alzheimer's disease. MacDonald is the Director of the Robarts Research Institute at The University of Western Ontario.

"If you have a stroke and survive, you have a very high risk of developing Alzheimer's disease or another dementia. These diseases are already taking a huge toll on society and costing billions of dollars in health care costs," says MacDonald. "With the aging population, it's a true growth illness."

The basic problem is how to prevent nerve cells in the brain from dying, and no longer being able to communicate information. The CIHR funding, which totals $1,086,625 over five years, will allow MacDonald to investigate the transmission process between nerve cells. In particular, he's interested in how a unique ion channel, TRPM2, couples with a glutamate receptor called NMDA to assist learning and memory. If this receptor becomes over-activated, for example during a stroke, it produces toxicity which damages or kills the brain cell. MacDonald has developed a peptide which will be tested to see if it'll prevent this toxic interaction, without interfering with normal activity.

MacDonald is also one of the co-authors of a Stroke-related study in the September 6th Advance Online Publication of the prestigious journal Nature Neuroscience. Scientists from the University of Toronto, Robarts Research Institute, the Mayo Clinic in Florida, and Kyoto University in Japan identified a way to prevent the death of neurons in the brain by inhibiting the expression of a channel called TRPM7. Michael Tymianski of Toronto was the lead on the study.

MacDonald is collaborating with researchers in Toronto, Japan and Ireland on the CIHR project. He's also part of an informal network of researchers across Canada dedicated to finding ways to prevent and treat Alzheimer's disease. "Finding new types of pharmacological therapy for Alzheimer's and related diseases is likely the most important health and social concern for Canada and the developed world."


'/>"/>

Contact: Kathy Wallis
kwallis3@uwo.ca
519-661-2111 x81136
University of Western Ontario
Source:Eurekalert

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... New studies published ... injured workers across 15 states. The outcomes examined in these studies include recovery ... care, and satisfaction with medical care. , “The goal of the studies is ...
(Date:5/25/2016)... , ... May 25, 2016 , ... CloudLIMS, joins an ... and Life Sciences Tech Solution Providers list of 2016 by CIOReview. , In a ... and Life Sciences Tech Solution Providers 2016 has been concluded with. The positioning is ...
(Date:5/25/2016)... ... May 25, 2016 , ... The World Molecular Imaging ... Molecular Imaging.” The focus of ADDMI-IG will be geared towards how using molecular ... issues. Through ADDMI-IG WMIS will provide a platform for productive discussions about the ...
(Date:5/25/2016)... ... 2016 , ... DKT International, one of the largest private ... to release their 2015 global impact data. In 2015, DKT served over 30 ... and 3.8 million unsafe abortions across 21 countries worldwide. , “We are ...
(Date:5/25/2016)... ... May 25, 2016 , ... Afrimesure specializes in ... and pharmaceutical, to food and HVAC facilities. Their knowledgeable staff also takes care ... For medical applications, Afrimesure offers a variety of MadgeTech systems available for sterilization ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
(Date:5/24/2016)... 24, 2016  Diana Russell suffers from a form ... the inside out.  This disease has put her in ... children and grandchildren to leave her home.  Because of ... cannot haul the wheelchair.  So if there is a ... Diana is left to wait for the bus. ...
Breaking Medicine Technology: